前往化源商城

Clinica Chimica Acta 2014-08-05

Normalization of urinary pteridines by urine specific gravity for early cancer detection.

Casey Burton, Honglan Shi, Yinfa Ma

文献索引:Clin. Chim. Acta 435 , 42-7, (2014)

全文:HTML全文

摘要

Urinary biomarkers, such as pteridines, require normalization with respect to an individual's hydration status and time since last urination. Conventional creatinine-based corrections are affected by a multitude of patient factors whereas urine specific gravity (USG) is a bulk specimen property that may better resist those same factors. We examined the performance of traditional creatinine adjustments relative to USG to six urinary pteridines in aggressive and benign breast cancers.6-Biopterin, neopterin, pterin, 6-hydroxymethylpterin, isoxanthopterin, xanthopterin, and creatinine were analyzed in 50 urine specimens with a previously developed liquid chromatography-tandem mass spectrometry technique. Creatinine and USG performance were evaluated with non-parametric Mann-Whitney hypothesis testing.USG and creatinine were moderately correlated (r=0.857) with deviations occurring in dilute and concentrated specimens. In 48 aggressive and benign breast cancers, normalization by USG significantly outperformed creatinine adjustments which marginally outperformed uncorrected pteridines in predicting pathological status. In addition, isoxanthopterin and xanthopterin were significantly higher in pathological specimens when normalized by USG.USG, as a bulk property, can provide better performance over creatinine-based normalizations for urinary pteridines in cancer detection applications.Copyright © 2014 Elsevier B.V. All rights reserved.

相关化合物

结构式 名称/CAS号 全部文献
氨水 结构式 氨水
CAS:1336-21-6
碘 结构式
CAS:7553-56-2
碘化钾 结构式 碘化钾
CAS:7681-11-0
L-生物喋呤 结构式 L-生物喋呤
CAS:22150-76-1
2-氨基-4-羟基蝶啶 结构式 2-氨基-4-羟基蝶啶
CAS:2236-60-4
异黄蝶呤 结构式 异黄蝶呤
CAS:529-69-1